EMMAC and Imperial College London manuscript to be published in peer-reviewed Cannabis and Cannabinoid Research Journal

LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical cannabis company, announces that the manuscript, “A comprehensive patient and public involvement programme evaluating perception of cannabis-derived medicinal products in the treatment of acute postoperative pain, nausea and vomiting using a qualitative thematic framework” has been published in ‘Cannabis and Cannabinoid Research’,…

ADDING MULTIMEDIA ZYUS Life Sciences to Acquire Revon Systems

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”) announced today that it has entered into a definitive agreement to acquire the Kentucky-based healthcare technology company Revon Systems, Inc. (“Revon”) in a share for share transaction. The closing date contemplated in the definitive agreement is July 31, 2019 or such other date as may be mutually agreed…

AM Best Places Credit Ratings of Century Insurance Company (Guam) Limited Under Review With Positive Implications

HONG KONG–(BUSINESS WIRE)–AM Best has placed under review with positive implications the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” of Century Insurance Company (Guam) Limited (CIC Guam) (Guam). These Credit Rating (rating) actions reflect the potential improvement in CIC Guam’s business profile, as well as the potential support…

 ZYUS Life Sciences to Acquire Revon Systems

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”) announced today that it has entered into a definitive agreement to acquire the Kentucky-based healthcare technology company Revon Systems, Inc. (“Revon”) in a share for share transaction. The closing date contemplated in the definitive agreement is July 31, 2019 or such other date as may be mutually agreed…

Global Industrial Hemp Market to Grow from $4.6 Billion in 2019 to $26.6 Billion by 2025, Recording a CAGR of 34% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Industrial Hemp Market by Type (Hemp Seed, Hemp Seed Oil, Hemp Fiber, and CBD Hemp Oil), Application (Food, Beverages, Personal Care Products, Textiles, and Pharmaceuticals), Source (Organic and Conventional), and Region – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The global industrial hemp market is projected to grow from…

Puma Biotechnology Presents Interim Results from the Biliary Tract Cohort of its Phase II SUMMIT Basket Trial of Neratinib at the ESMO World Congress on Gastrointestinal Cancer 2019

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, presented updated interim results from the biliary cancer cohort of SUMMIT, an ongoing Phase II basket trial examining the efficacy of neratinib in HER2-mutated cancers, at the European Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer 2019, currently taking place in Barcelona,…

BevCanna Awarded Health Canada Industrial Hemp Cultivation License

VANCOUVER, British Columbia–(BUSINESS WIRE)–Emerging leader in infused innovations, BevCanna Enterprises Inc. (BevCanna) (CSE:BEV) announced today that it has been awarded an Industrial Hemp Cultivation License from Health Canada, pursuant to the Cannabis Act (Canada) (the “Hemp License”). This highly-coveted license is a significant step in BevCanna’s plan to launch a portfolio of CBD-infused beverages and…

BIOTONE Announces Lab+Blends CBD Sleep Aid

SAN DIEGO–(BUSINESS WIRE)–BIOTONE has introduced Lab+Blends CBD Dream Drops, a drug-free, non-habit forming sleep aid. The revolutionary new offering features Cannabidiol (CBD), Melatonin and Vitamin B6, a powerful trio of ingredients proven to enhance sleep quality. Known for its anxiety-reducing benefits, THC-free CBD Extract, derived from industrial hemp, is calming and relaxing with no psychoactive…

MedMen Launches Partnership with Epilepsy Florida

LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) today announced a partnership with Epilepsy Florida, the principal agency overseeing epilepsy programs and services sponsored by the State of Florida. The organization serves over 400,000 Floridians who suffer from the condition and is the premier source of information for epilepsy and…